Gene · 8321
NIH grants1,683
NIH grants whose papers are about the gene, through NIH's grant-paper links.
461 to 480 of 1,683
Download this page as JSON| Grant | Title | FZD1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA226894 | Mechanisms and therapeutic targeting of colon cancer stem cell plasticity | 1 | 2022 |
| R01CA232419 | Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death | 1 | 2022 |
| R01DC017397 | Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal folds | 1 | 2022 |
| R01DE016289 | Mechanism of Cranial Neural Crest Cell Migration | 1 | 2022 |
| R01DK078803 | Novel insights into nutrient-dependent regulation of beta cell proliferation | 1 | 2022 |
| R01DK099134 | Regulation of Osteoblast Metabolism by Lrp5 | 1 | 2022 |
| R01DK115477 | Notch-mediated 5ARI resistance in human BPH | 1 | 2022 |
| R01DK115728 | Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy | 1 | 2022 |
| R01EB028320 | Programmable Synthetic Organelles Built from Disordered Proteins for Cellular Engineering | 1 | 2022 |
| R01ES029280 | Environmental Exposures, AHR Activation, and Placental Origins of Development | 1 | 2022 |
| R01GM105707 | Novel Regulatory Mechanisms of Drosophila Pumilio | 1 | 2022 |
| R01HD073104 | Systems Analysis of cell type differentiation in Xenopus development | 1 | 2022 |
| R01HD094380 | Mechanisms of actions(s) of simvastatin in uterine leiomyoma | 1 | 2022 |
| R01HD095520 | Biomechanics of Neural Tube Development using Brillouin-OCT Multimodality | 1 | 2022 |
| R01HL074186 | Pulmonary Hypertension in Genetically Modified Mice | 1 | 2022 |
| R01HL084553 | Genetic Signals in Ventricular Hypertrophy | 1 | 2022 |
| R01HL115195 | Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension | 1 | 2022 |
| R01HL141380 | Non-canonical WNT signaling in emphysema and lung regeneration | 1 | 2022 |
| R01NS105961 | Develop a combinatorial therapy for spinal cord injury | 1 | 2022 |
| R21AR077557 | A novel bone-targeting AAV-mediated gene therapy to promote bone formation in osteoporosis | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/grants?page=24